Why the study?
Do common CRP gene variants associate with baseline CRP levels and the risk of incident myocardial infarction or ischemic stroke in apparently healthy subjects?
Do common CRP gene variants associate with baseline CRP levels and the risk of incident myocardial infarction or ischemic stroke in apparently healthy subjects?
Genetic variants that increase CRP levels are not associated with an increased risk of incident MI or ischemic stroke, suggesting CRP may be a risk marker rather than a direct causal factor for atherothrombotic events.
Answers are grounded in this paper and cite their sources.
CRP variants do not link higher levels to MI or stroke risk; leaves open CRP as marker rather than causal factor.
C-reactive protein (CRP) is a well-documented marker of atherosclerotic cardiovascular disease risk. We resequenced CRP to identify a comprehensive set of common SNP variants, then studied and replicated their association with baseline CRP level among apparently healthy subjects in the Women's Health Study (WHS; n = 717), Pravastatin Inflammation/CRP Evaluation trial (PRINCE; n = 1,110) and Physicians' Health Study (PHS; n = 509) cohorts. The minor alleles of four SNPs were consistently associated in all three cohorts with higher CRP, while the minor alleles of two SNPs were associated with lower CRP (p < 0.05 for each). Single marker and haplotype analysis in all three cohorts were consistent with functional roles for the 5'-flanking triallelic SNP -286C>T>A and the 3'-UTR SNP 1846G>A. None of the SNPs associated with higher CRP were associated with risk of incident myocardial infarction (MI) or ischemic stroke in a prospective, nested case-control study design from the PHS cohort (610 case-control pairs). One SNP, -717A>G, was unrelated to CRP levels but associated with decreased risk of MI (p = 0.001). Taken together, these data imply significant interactions between both genetic and environmental contributions to the increased CRP levels that predict a greater risk of future atherothrombotic events in epidemiological studies.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: